Click Links Down Below for our

NewsLetter for

the Week of 12/12/25

YouTube Video

Audio Podcast

Questors: Global Mental Health Summit Workshop Agenda

Dear New York State, New York City Government Leaders, Interested Citizens, and Media,

VIRTUAL MEETING ON DECEMBER 12th, 2025.

Please join us.  Our Mission is to SAVE LIVES. The NYS Ibogaine Research Bill Petition drive for the New York State Bipartisan Ibogaine Research Bill 1817 aims to bring ibogaine and psychedelics as mental health therapeutics by FDA clinical research for OUD//SUD for health equity for veterans and tribal opioid/substance response.  Your support is urgent for legalization through evidence based therapeutics research.  Ibogaine SAVE LIVES, as it has for many already.

Where:  Virtual Meeting Invite Questors: Global Mental Health Summit 2025

You are invited to a Zoom Virtual Meeting for Global Mental Health Summit

When: Friday, Dec 12, 2025 10:30 AM – 3:00 PM Eastern Time (US and Canada)

Register in advance for this meeting:

Topic: 10:30AM-3:00pm December 12^th, .2025

KRFI Questors Virtual Global Mental Health Summit Workshop
Time: Dec 12, 2025 10:15 AM – 3:00 PM Eastern Time (US and Canada)
Knowledge Recovery Institute Questors  is inviting you to a scheduled Zoom meeting.

Topic: 10:30AM-3pm 12.12.2025 KRFI Questors Virtual Global Mental Health Summit Workshop

Time: Dec 12, 2025 10:15 PM Eastern Time (US and Canada)

Join Zoom Meeting

https://us06web.zoom.us/j/5462756074?pwd=7BshATUBgODobKAVQRFo4vwo9PaA7m.1&omn=89081474999

View meeting insights with Zoom AI Companion

https://us06web.zoom.us/launch/edl?muid=af352cf5-3220-44f0-b10c-28d249748b7e

Meeting ID: 546 275 6074

Passcode: KRFI

After registering, you will receive a confirmation email containing information about joining the meeting.

When:  10:30 am to 3 pm EST Questors Segment 1-3

Virtual Questors: Global Mental Health Summit

Agenda

December 12th, Friday  

Opening Remarks and Keynote Speaker

*10:30 -11:30 AM  Moderated by Paul Sladkus, with MyungHi S. Lee, this session explores “Health Equity and Human Rights in Ibogaine access for Americans”, focusing on the evolving public–private sector partnership model supporting Ibogaine treatment for veterans and Indigenous and Tribal communities. A central theme is Access and Benefit Sharing (ABS) for Intellectual Property—an essential component in the future of Ibogaine and psychedelic-based therapeutics. The presentation highlights emerging global biodiversity initiatives, including the development of natural products extractive libraries that contribute to UN Convention on Biological Diversity (UNCBD)–aligned efforts in genomics, chemical data repositories, and carbon-sequestration-linked technologies. These initiatives support Indigenous-led entheogenic agricultural solutions and sustainable development protocols in the United States and across emerging market.

A key focus is KRFI’s Ibogaine IP shareholding model, designed to create royalty-based botanical drug pathways for tropical nations participating in Ibogaine and psychedelic research. This ABS-IP framework advances a sustainable public–private coordinating mechanism for long-term benefit sharing, capacity building, and in-country development. Use Case: Central America. The session will highlight the example of Costa Rica, featuring collaboration between national partners and the KRIBB Extractive Library. This includes the development of ABS-IP platforms for genomics and chemical data silos, private-sector registration pathways, and participation in the Forever Forest Program, which aims to support tropical nations in sustainable biodiversity management and equitable access to the economic benefits of natural products.

*11:30 -12:30 AM   “Technology & Innovation: AI, Social Responsibility & the American Ibogaine Initiative” This session will connect Andrew Romero InferenceFrame’s AI infrastructure with the policy and clinical mission of the American Ibogaine Initiative, with MyungHi S. Lee and KRFI Questors. Key discussion areas include:

* AI-enhanced investment frameworks for Ibogaine deployment

* Public–private partnership models supporting mental health reform

* Responsible funding strategies for bipartisan state-level Ibogaine bill

* Ethical scaling, oversight, and corporate social responsibility

* Building national infrastructure for Ibogaine-based mental health interventions

Together, the speakers outline how AI, biotechnology, and responsible investment can accelerate safe, equitable, and evidence-based Ibogaine access for veterans, Indigenous communities, and Americans facing mental health and addiction crises. Andrew Romero leads the development of high-reliability AI at InferenceFrame, where he designs and deploys advanced structured reasoning systems that strengthen decision-making in high-stakes environments. His work centers on Neuro-Symbolic (NeSy) approaches that integrate mathematical and logical reasoning, enabling AI systems to perform with greater precision and significantly reduced data requirements. InferenceFrame’s technology has been used to generate actionable insights for companies, investment funds, and research organizations, supported by strategic institutional funding. The company has also established cost-sensitive licensing agreements, allowing scalable access to its reasoning systems. These AI platforms demonstrate strong performance across diverse domains, including:

* Financial markets & capital allocation

* Robotics & autonomous system

* Mathematical and scientific discovery

* Risk assessment and high-stakes decision support

Andrew has also developed a suite of AI-driven investment banking tools, supporting capital structuring, due diligence, and near-automated deal execution. These technologies help reduce operational bottlenecks and increase accuracy in financial decision-making. InferenceFrame’s systems are adopted through partnerships with major FINRA-member firms, including GT Securities, where Andrew serves as Director.

* 12:30 – 2:30 PM  Moderated Paul Sladkus, and MyungHi S. Lee, with this session features collaborative framework for an Ibogaine Clinical R&D Alliance focused on FDA/MHRA/EMEA/ANVISA–registered clinical trial reporting and mechanism-of-action research.  The discussion highlights the KRFI Questors open-source clinical data platform, designed to address a persistent challenge in psychiatric research: fewer than 10% of clinical studies adequately assess double blinding integrity, as a foundational element of clinical trial design. With transparent, shared, and high-quality data, the field faces limitations in cost efficiency, reproducibility, and the ability to resolve the consequences of unblinding on data interpretation—issues that are especially critical for advancing Ibogaine and psychedelic-based mental health therapeutics.  The patient with placebo will experience withdrawal and possible unpredictable adverse reactions for the participants.

Questors aims to establish the Ibogaine & Psychedelic Clinical Evidence Assessment Working Group (I&P CEA-WG). As clinical programs grow in complexity—particularly those integrating psychotherapy with pharmacological interventions—KRFI is convening an  Ibogaine and Psychedelic Clinical Evidence Assessment Working Group (I & P CEA-WG). This online data review platform generates reporting by the research institutes with a parallel track on policy and legal advisory group conducted at the P Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics,.  Independent Ibogaine and Psychedelic Clinical Evidence Assessment Working Group (I & PCEA-WG).works with parallel track with online CTMS with institutional partnership and safety and pharmacovigilance and technical platform to aid the institutions, practitioners, and research community.

Current State of the National Ibogaine Consortium endeavors by Bryan Hubbard and Rick Perry Co-founders of the Americans for Ibogaine and its role in a Public–Private Sector Partnership in Ibogaine Clinical Research.  The New York State Ibogaine Research Bill Action Plan for January 2026, This announcement aims to address the including:

* Upcoming NYS Senate hearings featuring Ibogaine testimonials

* Coordinated state-level action plans in NYS, Texas, Arizona, Ohio, and Colorado

* Responses from state authorities across the United States

Policy and Mental Health Strategy: The discussion will focus on mental health policy initiatives in New York State, exploring the allocation of $12 billion USD toward mental health and addiction programs. Special emphasis will be placed on the NYS Ibogaine Research Bill, led by Bipartisan Senate sponsors Natalie Rodriguez (D) and Jacob Ashby (R) during the January 2026 Hearing.

Speakers Biography

Andrew Romero is the Founder and Principal of InferenceFrame and a Director at GT Securities, where he serves as Managing Director for the Global Mental Health Security Fund. His work integrates investment banking with advanced data science and AI, particularly in the development of structured reasoning systems designed for reliability in high-stakes environments. Through InferenceFrame, Andrew has led the creation of AI and data-driven technologies that support situational reasoning, grounded in mathematical and logical frameworks and informed by a NeSy (Neuro-Symbolic) approach. These systems are engineered to deliver dependable performance while significantly reducing data requirements. InferenceFrame has provided insights and analytical solutions to numerous companies, investment funds, and research organizations, and has established cost-sensitive licensing agreements for its proprietary reasoning platforms. Strategic institutional funding has supported the continued development and demonstrable performance of these systems across diverse domains. Andrew’s work spans multiple application areas, including financial markets, robotics, and mathematical and scientific discovery, with a wide range of future use cases under exploration. In the investment banking domain, he has developed AI-driven solutions for capital structuring, due diligence, and near-automated deal execution. His technology is partnered with several leading FINRA-member firms, including GT Securities, where his expertise supports innovative financial solutions at the intersection of AI and global mental health strategy.

MyungHi S. Lee, DAOM, is the Founder and CEO of the Knowledge Recovery Foundation/Institute (KRFI), established in 1989 with a focus on global health challenges including malaria, tuberculosis, and HIV/AIDS. Under her leadership, KRFI has addressed major policy and implementation barriers related to Artemisinin Combination Therapy (ACT), contributing to advancements in artemisinin supply—such as the development of supercritical fluid extracts (SFE), high-yield cultivars, Drug Master Files (DMFs), and ACT clinical trials in Africa. Her collaborative work with Dr. Lee Sang Wook supported the WHO Secretary General’s Rollback Malaria initiative from 2004 to 2010, particularly in areas of ABS-IP policy and ACT deployment.  MyungHi is a Natural Products Pharmacognosist with specialized expertise in supercritical extraction technologies, prodrug formulation, and orally disintegrating tablet (ODT) manufacturing across the UK and Korea. She has more than 25 years of experience navigating regulatory compliance and has organized joint conferences with KSEA on GMP manufacturing, DSEA Act compliance, and FDA regulatory pathways for botanical drug development.  Currently, KRFI is expanding its work in Questors clinical trial management systems (CTMS) and reporting platforms for Ibogaine and psychedelics. KRFI’s CRO division, KRFI Questors, is dedicated to education in drug safety and pharmacovigilance, and actively supports the development of FDA clinical trials for Ibogaine targeting opioid and substance use disorders (OUD/SUD).

Presenter:  Reverend Paul Sladkus, All Faiths and Spiritual, Host of over 7,500 Good News Broadcast Programs, with over 1,000 on Health and Wellness.  Former Executive with CBS and PBS/Channel 13 TV.  Worked on the original Award Winning Brain Series for PBS. www.pausetheworldforpeace.org. THERE IS NO PEACE WHEN YOU ARE A DRUG ADDICT.

MyungHi Sonserai Lee DAOM

Knowledge Recovery Foundation/Institute
e:MyungHi.s.lee@krfi.org
t:917 913 4543; 212 722 3960
Www.KRFI.org
Www.krfi.org/psa
www.krfi.org/ press announcement
Www.KRFI.org/knowyourdrugs
www.krfi.org/NYS ibogaine bipartisan bill

Click Link Down Below for our

Newsletter for

the Week of 11/19/25

YouTube Video

Audio Podcast

Dear Friends, Members, Media, and those who care about DRUG ADDICTION,  

BE HAPPY YOU ARE NOT AN ADDICT, AS THERE IS NO PEACE…

Good News has been working on the public relations and marketing for an Organic Botanical Medicine from MOTHER EARTH for those who are ADDICTED TO DRUGS. The BARK OF THE PLANT is used from the plant, and it is called IBOGAINE, not for all, but many using it attest to its quick success…yay!   BTW – Do you know that ASPIRIN COMES FROM THE BARK OF A WILLOW TREE! MOTHER EARTH IS IN CHARGE! 

We invite you to attend a Mental Health Summit on December 11-12 at the New York Academy of Sciences, where George Soros will be honored. www.krfi.org Information is in the Press Release below and please sign the petition to urge the Senate, in January 2026 to pass Bill S1817, https://www.nysenate.gov/legislation/bills/2025/S1817 for more research, as New York State has Billions to make this happen and potentially save lives. Other states have passed bills and are doing research and NEW YORK STATE HAS ALWAYS BEEN THE LEADER.  

Reverend Paul Sladkus, All Faiths and Spiritual 

and the Earth and Peace Day Team. www.pausetheworldforpeace.org call 212 647 1212 

Emergency –

A New Organic BOTANICAL MEDICINE “Short Recovery”

Solution to Drug Addiction is Here

Emergency – A New Organic BOTANICAL MEDICINE “Short Recovery” Solution to Drug Addiction is Here

For Immediate Release:

New York, NY – The Knowledge Recovery Foundation Institute (KRFI) has been involved with a natural, botanical drug product derived from the bark of the Voacanga iboga plant *, known as ibogaine. To date, numerous European organizations and Stanford University have reported the use of IBOGAINE WITH GREAT SUCCESS.

Myung Hi Sonserai Lee, the founder of KRFI, states, * * 

We have been working on this for 40 years, and we are excited to see New York pass a bipartisan bill,Senate Bill S1817, which requires the NYS Governor Hochul and Commissioner Cunningham of the NYS Office of Addiction Services and Supports (OASAS) and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment, opioid, and substance addiction. Send your petition signature and a letter requesting NYS Governor Hochul and Commissioner Cunningham of the NYS Office of Addiction Services and Supports (OASAS) to sign the bill by January 2026, to meet the NYS Senate and Assembly deadline. 

Contact www.krfi.org/NYS Ibogaine Research Bill. Write to Governor.Hochul@exec.ny.gov, and Senator Rodriguez for (BiPartisan Bill A6210 and S1817) Write to: Chinazo.Cunningham@ny.gov

KRFI looks forward to the Governor of New York implementing the bill, which could potentially save many people from addiction to opioids and Substance Use conditions for recovery.

KRFI is part of a private-public sector partnership consortium for Americans for Ibogaine that supports the Texas State Government in passing a bipartisan bill that allocated $ 50 million to ibogaine clinical trials. KRFI, over the past 40 years, has developed Original Ibogaine extraction and formulation IPs with Access for Benefit Sharing of the IPs and the Royalty based private public sector partnership with Biodiversity + Carbon credits for partnering States/Countries that will immediately allow for U.S. trials to begin and is reaching out to a matching fund by Global Mental Health Security Fund for the NYS $300 million Ibogaine Clinical Research Bill.

Let’s bring everyone together to rally behind healing. Investors, wellness practitioners, advocates – Let’s help pass this bipartisan bill. To help proceed, here is a link for the supporting bill: Go to: https://www.nysenate.gov/legislation/bills/2025/S1817

Additionally, KRFI is organizing a SUMMIT in New York on December 11 and 12, 2026. Topics to be included: www.krfi.org/NYS Ibogaine Research Bill petition

Support for Ibogaine has come from a private-public sector partnership, including grants and donations from the NYS Ibogaine Research Bill, as well as matching fund sponsors/investors, and consortium members for clinical trial alliances.

Bryan Hubbard (Financial Times) – Economic Case for Recovery Investment: “ 

Americans for Ibogaine unites clinicians, researchers, and advocates to promote science-based awareness and reduce stigma around ibogaine therapy. Through education, policy engagement, and community partnerships, we strive to expand safe and legal access to medically supervised care.”

George Soros – Philanthropy & Global Mental Health Finance

“I am deeply touched by your thoughtfulness and by the Questors: Global Mental Health Summit Committee’s recognition of my work in the field of mental health. Our work and actions have always been rooted in legality, transparency, and integrity. The truth will stand clear, revealing that my efforts have always been dedicated to the right cause and the greater good.  The trust and support I have received over the years from individuals, organizations, and institutions like the Knowledge Recovery Institute serve as a foundation of credibility. Together, these relationships will continue to inspire confidence and foster unlimited growth in our shared mission to improve mental health worldwide.”

NBA player Stéphane Lasme has stated· “Beyond physical trauma, players grapple with anxiety and identity loss after their careers end. Ibogaine has been a ‘game-changer’ for mental health, helping players find a new perspective and reconnect with themselves.”

NBA player Lamar Odom discusses his ibogaine treatment; “he has recovered a sense of choice, even during tough life moments like losing his ‘best man’ (Kobe Bryant), and in other situations that would have previously been triggers for him to return to drugs. “Just as fast as I say cocaine,” Lamar reflects, “the thought of it leaves my mind.” This interview is a testament to Odom’s recovery, which he attributes to ibogaine, to will, and to God, and serves as inspiration to others facing personal challenges. “Now I just wanna try to use my story to help people, because if I could get through that… I know they could; it shouldn’t take 12 strokes and 6 heart attacks for anybody else to get through it.”

Currently, active clinical trials are being conducted in Norway, Canada, and the UK. The Ibogaine Clinical Research Act is seeking a global alliance for the clinical trial and drug supply chain security through Access for Benefit Sharing – IP model.

* Iboga is a rainforest perennial shrub (Voacanga iboga), from which IBOGAINE is derived, native to Central Africa. A member of the Apocynaceae family, indigenous to Gabon, the Democratic Republic of the Congo, and the Republic of the Congo, it is cultivated across Central Africa for its medicinal and other effects. KRFI has identified central and South American cultivars for indigenous collective production under Access for Benefit Sharing and IP registration for the local PPP framework, and In-country coordination for the Ministry of Health Mental Health Program and UNCED.

** We request that the New York State Senate and Assembly introduce and pass a bipartisan bill authorizing by January 2026:

– Allocation of NYS $12 Bn Opioid Settlement Funds for OASIS Commission for Opioid Abatement for FDA-approved Ibogaine trials “An Ibogaine Clinical Research Bill”

– Establishment of the Mental Health Security Hyperledger Security (1) Access for Benefit Sharing – Intellectual Property Rights (ABS-IP) for a PPP framework for secure clinical and supply chain data on the hyperledger dashboard

– State adoption of the Natural Medicine Health Act for plant-based treatment research and veterans and indigenous tribes for health equity by the In-state Clinical Trial Management and Reporting partnership (CTMS-Reporting) for the first responders and practitioner training for pharmacovigilance (Drug – Drug interactions affecting our society) on entheogenic ibogaine and psychedelics 

This bill would create a legal and financial framework for New York to lead national policy on breakthrough addiction treatments.

Background for KRFI 

Join Us at the Global Mental Health Summit on December 11-12, 2025, at the New York Academy of Medicine. December 12th, 2025, Gala Award Ceremony Dinner honoring George Soros, Open Society Foundation for the Lifetime Humanitarian Award.

Join us for Lucy Walker’s Documentary Feature Film Screening on “Ibogaine Story: Of Night and Light” on December 11th, 2025, 6-8 pm film screening with cocktail event 8-9 pm; 

Keynote: Lucy Walker, Filmmaker 4-6 pm Screening on December 12th, 2025, at the New York Academy of Medicine with Gala Award Ceremony Dinner Event starting with a cocktail at 6 pm for the 7 pm Gala Dinner.

The Knowledge Recovery Foundation Institute is a Public Benefit Corporation with 501(c)(3) nonprofit status in advancing global addiction recovery research through clinical, technological, and policy innovation. KRFI leads the Global Mental Health Security Fund initiative to accelerate equitable access to psychedelic-assisted therapies and ensure international collaboration through Access & Benefit Sharing (ABS) models.

All Charitable donations for Knowledge Recovery Institute, a 501(c)(3) tax-exempt public charity – Tax ID# 73-3223951. All Contributions are tax-deductible to the extent allowable by law.

Note: IBOGAINE is not FDA-approved, and it is guided under Medically Assisted Therapy under regulatory compliance. Not all patients can use IBOGAINE, so speak to your doctor about it for future use.

For More Information contact: Info@krfi.org; KRFI PR & Media: paul.sladkus@Krfi.org; 212 647 1212 and/or KRFI Questors Private Public Sector Partnership: andres.cordova@krfi.org 214-725-7088

Donate@krfi.org and Schedule a meeting with PPP membership: Membership@krfi.org

To watch the PSA, go to: https://www.krfi.org/psa

KRFI will also be a supporter of the Times Square Earth Day concert on April 22, 2026. www.pausetheworldforpeace.org

Please share with your community all our Good News. 

We are ALL IN THIS TOGETHER FOR PEACE AND MOTHER EARTH.

Please donate here, as we have incurred financial losses on our peace efforts and continue to expand them.   https://goodnewsplanet.com/pausetheworld/peace-day-donations/

For Nonprofit Donations for our Peace and Earth Day Events go to:

https://goodnewsplanet.com/pausetheworld/peace-day-donations/

STAY WELL

LET’S GROW TOGETHER. GOOD NEWS MOTTO: “All we are is what we are with each other.” Zeal

With Respect. Love and May Peace Prevail on Earth,  For Information Contact: 

Reverend Paul Sladkus, All Faiths and Spiritual,

Founder, Good News Corporation 501 C 3 212 647 1212 paul.sladkus1@gmail.com  and our Good News and Peace Worldwide Team who make our Peace Day 9/21 happen.

www.pausetheworldforpeace.org,www.goodnewsplanet.TV, www.youtube.com/goodnewsbroadcast

Social Networks: www.Facebook.com/PaulSladkus, LinkedIn Paul Sladkus, Twitter/X Good News to Go, Instagram PausetheWorld

LET’S GROW TOGETHER. GOOD NEWS MOTTO: ALL WE ARE IS WHAT WE ARE WITH EACH OTHER. ZEAL

For more information contact: 

Reverend Paul Sladkus, All Faiths and Spiritual 212 647 1212

New York, NY, Montauk, NY